Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 28
- Next page
Title Sort descending | Authors | Year | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Our older population: donors as well as recipients? | Goldman M, O'Brien S | 2017 | ISBT Sci Ser | View Our older population: donors as well as recipients? | Health care providers | Clinical research |
Outbreak of acute hepatitis B virus infection associated with exposure to acupuncture | Rempel S, Murti M, Buxton J, Stephens W, Watterson M, Andonov A, Fung C, Ramler G, Bigham M, Lem M | 2016 | Canada Communicable Disease Report | View Outbreak of acute hepatitis B virus infection associated with exposure to acupuncture | Health care providers | Clinical research |
Outbreak of shigellosis in a homeless shelter with healthcare worker transmission - British Columbia, April 2015 | Murti M, Louie K, Bigham M, Hoang LMN | 2015 | Infect Control Hosp Epidemiol | View Outbreak of shigellosis in a homeless shelter with healthcare worker transmission - British Columbia, April 2015 | Health care providers | Clinical research |
Outcomes of both abbreviated hyper-CVAD induction followed by autologous hematopoietic cell transplantation and conventional chemotherapy for mantle cell lymphoma: a 10-year single-centre experience with literature review | Alwasaidi TA, Hamadah A, Altouri S, Tay J, McDiarmid S, Faught C, Allan D, Huebsch L, Bredeson C, Bence-Bruckler I | 2015 | Cancer Med | View Outcomes of both abbreviated hyper-CVAD induction followed by autologous hematopoietic cell transplantation and conventional chemotherapy for mantle cell lymphoma: a 10-year single-centre experience with literature review | Health care providers | Clinical research |
Overcoming the deceptively low viability of CD45+ cells in thawed cord blood unit segments | Pasha R, Halpenny M, Pineault N | 2019 | Vox Sang | View Overcoming the deceptively low viability of CD45+ cells in thawed cord blood unit segments | Researchers | New or improved product or process |
Oxford's Systematic Review Initiative: leading by example in evidence-based transfusion medicine | Fergusson DA | 2016 | Transfus Med | View Oxford's Systematic Review Initiative: leading by example in evidence-based transfusion medicine | Researchers | Clinical research |
p38 mitogen-activated protein kinase regulates mitochondrial function and microvesicle release in riboflavin- and ultraviolet light–treated apheresis platelet concentrates | Chen Z, Schubert P, Bakkour S, Culibrk B, Busch MP, Devine DV | 2017 | Transfusion | View p38 mitogen-activated protein kinase regulates mitochondrial function and microvesicle release in riboflavin- and ultraviolet light–treated apheresis platelet concentrates | Researchers | Basic research |
p38MAPK is involved in apoptosis development in apheresis platelet concentrates after riboflavin and ultraviolet light treatment | Chen Z, Schubert P, Culibrk B, Devine DV | 2014 | Transfusion | View p38MAPK is involved in apoptosis development in apheresis platelet concentrates after riboflavin and ultraviolet light treatment | Researchers | Basic research |
Paracrine Factors Released by Osteoblasts Provide Strong Platelet Engraftment Properties | Abu-Khader A, Law KW, Jahan S, Manesia JK, Pasha R, Hovey O, Pineault N | 2019 | Stem Cells | View Paracrine Factors Released by Osteoblasts Provide Strong Platelet Engraftment Properties | Researchers | Basic research |
Paroxysmal cold hemoglobinuria: a difficult diagnosis in adult patients | Zeller MP, Arnold DM, Al Habsi K, Cserti-Gazdewich C, Delage G, Lebrun A, Heddle NM | 2017 | Transfusion | View Paroxysmal cold hemoglobinuria: a difficult diagnosis in adult patients | Health care providers | Clinical research |
Part 2: Evidence Evaluation and Management of Conflicts of Interest: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care | Morrison LJ, Gent LM, Lang E, Nunnally ME, Parker MJ, Callaway CW, Nadkarni VM, Fernandez AR, Billi JE, Egan JR, Griffin RE, Shuster M, Hazinski MF | 2015 | Circulation | View Part 2: Evidence Evaluation and Management of Conflicts of Interest: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care | Health care providers | Benchmarking and standard setting |
Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes | Pierce GF, Iorio A | 2018 | Haemophilia | View Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes | Health care providers | New or improved product or process |
Pathogen inactivation by riboflavin and ultraviolet light illumination accelerates the red blood cell storage lesion and promotes eryptosis | Qadri SM, Chen D, Schubert P, Perruzza DL, Bhakta V, Devine DV, Sheffield WP | 2017 | Transfusion | View Pathogen inactivation by riboflavin and ultraviolet light illumination accelerates the red blood cell storage lesion and promotes eryptosis | Researchers | Basic research |
Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Devine DV | 2018 | JAMA Oncol | View Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Health care providers | New or improved product or process |
Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Devine DV | 2018 | JAMA Oncol | View Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Researchers | New or improved product or process |
Pathogen Inactivation Technologies: The Advent of Pathogen-Reduced Blood Components to Reduce Blood Safety Risk | Devine DV, Schubert P | 2016 | Hematol Oncol Clin North Am | View Pathogen Inactivation Technologies: The Advent of Pathogen-Reduced Blood Components to Reduce Blood Safety Risk | Blood operators | Other |
Pathogen inactivation treatment of plasma and platelet concentrates and their predicted functionality in massive transfusion protocols | Arbaeen AF, Schubert P, Serrano K, Carter CJ, Culibrk B, Devine DV | 2017 | Transfusion | View Pathogen inactivation treatment of plasma and platelet concentrates and their predicted functionality in massive transfusion protocols | Researchers | Basic research |
Pathogen reduction of whole blood: Supplementing fibrinogen partly corrects clot formation in a massive transfusion model | Arbaeen AF, Schubert P, Sheffield WP, Devine DV | 2021 | Transfusion | View Pathogen reduction of whole blood: Supplementing fibrinogen partly corrects clot formation in a massive transfusion model | Researchers | New or improved product or process |
Pathogen reduction technologies: The pros and cons for platelet transfusion | Magron A, Laugier J, Provost P, Boilard E | 2018 | Platelets | View Pathogen reduction technologies: The pros and cons for platelet transfusion | Blood operators | Basic research |
Pathogen-reduced buffy coat platelets | Blais-Normandin I, Tordon B, Anani W | 2022 | Blood.ca website | View Pathogen-reduced buffy coat platelets | Health care providers | Benchmarking and standard setting |
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP) | Zufferey A, Kapur R, Semple J | 2017 | J Clin Med | View Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP) | Researchers | Basic research |
Pathogenesis of immune thrombocytopenia | Cines DB, Cuker A, Semple JW | 2014 | Presse Med | View Pathogenesis of immune thrombocytopenia | Researchers | Clinical research |
Pathophysiology of immune thrombocytopenia | Li J, Sullivan JA, Ni H | 2018 | Curr Opin Hematol | View Pathophysiology of immune thrombocytopenia | Researchers | Other |
Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference | Mueller MM, Van Remoortel H, Meybohm P, Aranko K, Aubron C, Burger R, Carson JL, Cichutek K, De Buck E, Devine D, Fergusson D, Folléa G, French C, Frey KP, Gammon R, Levy JH, Murphy MF, Ozier Y, Pavenski K, So-Osman C, Tiberghien P, Volmink J, Waters JH, Wood EM, Seifried E, ICC PBM Frankfurt Group | 2019 | JAMA | View Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference | Researchers | Clinical research |
Patterns of joint damage in severe haemophilia A treated with prophylaxis | Goren R, Pullenayegum E, Blanchette VS, Dover S, Carcao M, Israels SJ, Chan A, Rivard GE, Steele M, Cloutier S, Klaassen RJ, Sinha R, Price VE, Laferriere N, Paradis E, Wu JK, Feldman BM | 2021 | Haemophilia | View Patterns of joint damage in severe haemophilia A treated with prophylaxis | Health care providers | Clinical research |
Paying it forward: Why we need YOU to give blood | Callum J | 2017 | Blood.ca website | View Paying it forward: Why we need YOU to give blood | Health care providers | Other |
Peanut and fish allergy due to platelet transfusion in a child | Ching JC, Lau W, Hannach B, Upton JE | 2015 | CMAJ | View Peanut and fish allergy due to platelet transfusion in a child | Health care providers | Clinical research |
Peculiarities of studying the effects of pathogen reduction technologies on platelets | Osman A, Hitzler WE, Provost P | 2016 | Proteomics Clin Appl | View Peculiarities of studying the effects of pathogen reduction technologies on platelets | Researchers | Basic research |
PEGylation prevents bacteria-induced platelet activation and biofilm formation in platelet concentrates | Greco CA, Maurer-Spurej E, Scott MD, Kalab M, Nakane N, Ramirez-Arcos SM | 2011 | Vox Sang | View PEGylation prevents bacteria-induced platelet activation and biofilm formation in platelet concentrates | Researchers | Basic research |
Peptide-Modified Surfaces for Binding Carbamylated Proteins from Plasma | Ma Y, Hadjesfandiari N, Doschak M, Devine D, Tonelli M, Unsworth L | 2021 | Langmuir | View Peptide-Modified Surfaces for Binding Carbamylated Proteins from Plasma | Researchers | Basic research |
Perforation des sacs de composants sanguins | Shimla S, Jenkins C, McTaggart K | 2018 | Blood.ca website | View Perforation des sacs de composants sanguins | Other | Other |
Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL HIT-Ab(PF4-H)] for the diagnosis of immune heparin-induced thrombocytopenia | Warkentin TE, Sheppard J-AI, Linkins L-A, Arnold DM, Nazy I | 2017 | Thromb Res | View Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL HIT-Ab(PF4-H)] for the diagnosis of immune heparin-induced thrombocytopenia | Researchers | Clinical research |
Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria | Gabe C, Sirotich E, Li N, Ivetic N, Nazy I, Smith J, Kelton JG, Arnold DM | 2021 | Br J Haematol | View Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria | Health care providers | Clinical research |
Performance of Stool-testing Recommendations for Acute Gastroenteritis When Used to Identify Children With 9 Potential Bacterial Enteropathogens | Kim K, Tarr GAM, Chui L, Drews S, Pang X-L, Lee BE, Ali S, Nettel-Aguirre A, Vanderkooi OG, Berenger BM, Dickinson J, Tarr PI, MacDonald J, Freedman SB | 2018 | Clin Infect Dis | View Performance of Stool-testing Recommendations for Acute Gastroenteritis When Used to Identify Children With 9 Potential Bacterial Enteropathogens | Health care providers | Clinical research |
Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations | Iorio A, Edginton AN, Blanchette V, Blatny J, Boban A, Cnossen M, Collins P, Croteau SE, Fischer K, Hart DP, Ito S, Korth-Bradley J, Lethagen S, Lillicrap D, Makris M, Mathôt R, Morfini M, Neufeld EJ, Spears J | 2018 | Res Pract Thromb Haem | View Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations | Health care providers | Clinical research |
Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale | Arnold D, Jamula E, Heddle N, Cook R, Hsia C, Sholzberg M, Lin Y, Kassis J, Blostein M, Larratt L, Amini S, Schipperus M, Carruthers J, Lane S, Li N, G. Kelton J | 2019 | Thromb Haemost | View Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale | Researchers | Clinical research |
Perinatal issues in transfusion practice | Lieberman L, Clarke G, Svensson A | 2020 | AABB Technical Manual, 20th Edition | Health care providers | Benchmarking and standard setting | |
Perioperative Management of Dabigatran: A Prospective Cohort Study | Schulman S, Carrier M, Lee AY, Shivakumar S, Blostein M, Spencer FA, Solymoss S, Barty R, Wang G, Heddle N, Douketis JD | 2015 | Circulation | View Perioperative Management of Dabigatran: A Prospective Cohort Study | Health care providers | Clinical research |
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant | Douketis JD, Spyropoulos AC, Duncan J, Carrier M, Le Gal G, Tafur AJ, Vanassche T, Verhamme P, Shivakumar S, Gross PL, Lee AYY, Yeo E, Solymoss S, Kassis J, Le Templier G, Kowalski S, Blostein M, Shah V, MacKay E, Wu C, Clark NP, Bates SM, Spencer FA, Arnaoutoglou E, Coppens M, Arnold DM, Caprini JA, Li N, Moffat KA, Syed S, Schulman S | 2019 | JAMA Intern Med | View Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant | Health care providers | Benchmarking and standard setting |
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial | Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Amini S, Schipperus M, Lim W, Vishnu P, Warner M, Carruthers J, Li N, Lane S, Kelton JG | 2020 | Lancet Haematol | View Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial | Health care providers | Clinical research |
Perioperative transfusion-related acute lung injury: The Canadian Blood Services experience | Alam A, Huang M, Yi Q-L, Lin Y, Hannach B | 2014 | Transfus Apher Sci | View Perioperative transfusion-related acute lung injury: The Canadian Blood Services experience | Health care providers | Other |
Peripheral blood monocyte-derived chemokine blockade prevents murine antibody-mediated transfusion-related acute lung injury (TRALI) | McKenzie CG, Kim M, Singh TK, Milev Y, Freedman J, Semple JW | 2014 | Blood | View Peripheral blood monocyte-derived chemokine blockade prevents murine antibody-mediated transfusion-related acute lung injury (TRALI) | Researchers | Basic research |
Persistence of CRISPR/Cas9 gene edited hematopoietic stem cells following transplantation: A systematic review and meta-analysis of preclinical studies | Maganti HB, Bailey AJM, Kirkham AM, Shorr R, Pineault N, Allan DS | 2021 | Stem Cells Transl Med | View Persistence of CRISPR/Cas9 gene edited hematopoietic stem cells following transplantation: A systematic review and meta-analysis of preclinical studies | Researchers | Basic research |
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients | Isho B, Abe KT, Zuo M, Jamal AJ, Rathod B, Wang JH, Li Z, Chao G, Rojas OL, Bang YM, Pu A, Christie-Holmes N, Gervais C, Ceccarelli D, Samavarchi-Tehrani P, Guvenc F, Budylowski P, Li A, Paterson A, Yue FY, Marin LM, Caldwell L, Wrana JL, Colwill K, Sicheri F, Mubareka S, Gray-Owen SD, Drews SJ, Siqueira WL, Barrios-Rodiles M, Ostrowski M, Rini JM, Durocher Y, McGeer AJ, Gommerman JL, Gingras AC | 2020 | Sci Immunol | View Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients | Researchers | Clinical research |
Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality | Leatherdale A, Stukas S, Lei V, West HE, Campbell CJ, Hoiland RL, Cooper J, Wellington CL, Sekhon MS, Pryzdial ELG, Conway EM | 2022 | Med Microbiol Immunol | View Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality | Health care providers | Clinical research |
Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry | Khan H, Gallant RC, Zamzam A, Jain S, Afxentiou S, Syed M, Kroezen Z, Shanmuganathan M, Britz-McKibbin P, Rand ML, Ni H, Al-Omran M, Qadura M | 2020 | Diagnostics | View Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry | Health care providers | Clinical research |
Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009–2015 | Crowcroft NS, Schwartz KL, Chen C, Johnson C, Li Y, Marchand-Austin A, Bolotin S, Jamieson FB, Drews SJ, Russell ML, Svenson LW, Simmonds K, Mahmud SM, Kwong JC | 2019 | Vaccine | View Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009–2015 | Researchers | Clinical research |
Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin | Scott BM, Matochko WL, Gierczak RF, Bhakta V, Derda R, Sheffield WP | 2014 | PLoS One | View Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin | Researchers | Basic research |
Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH | Ragni MV, Croteau SE, Morfini M, Cnossen MH, Iorio A | 2018 | J Thromb Haemost | View Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH | Health care providers | Basic research |
Pharmacy hydroxyurea education materials for patients with sickle cell disease: An environmental scan and assessment of accuracy | Cervi A, Diamantouros A, Azzam M, Lane SJ, Sapru H, Verhovsek M | 2020 | Pediatr Blood Cancer | View Pharmacy hydroxyurea education materials for patients with sickle cell disease: An environmental scan and assessment of accuracy | Researchers | Benchmarking and standard setting |